Position in GSK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,503,405
-$114,379 QoQ
Shares Held
28,680
-2.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#302
of 1,033 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 11%
Shared 0%
None 89%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DENALI ADVISORS LLC holds $21,250,231 across 5 Drug Manufacturers - General names. GSK ranks #3 (7.1% of the industry book) .
All Filings in GSK
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,503,405 | 28,680 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,617,784 | 29,313 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,366,891 | 27,873 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $826,082 | 19,140 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,223,001 | 31,849 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,114,820 | 28,777 | Shares | Sole | 2025-05-05 | |
| 2024-09-30 | $390,117 | 9,543 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||